EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsAll authors declare they have no conflict interests. Competing interests All authors declare they have no conflict interests."
Funding Disclosure
Evidence found in paper:
"Funding This study was funded by Shanxi Province “136” Revitalization Medical Project Construction Funds, The National Natural Science Foundation of China (82073090 to Lei Zhang)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025